Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
08/1999
08/05/1999WO1999038985A2 HIGHLY EFFICIENT CONTROLLED EXPRESSION OF EXOGENOUS GENES IN $i(E. COLI)
08/05/1999WO1999038984A1 Process for producing peptide with the use of accessory peptide
08/05/1999WO1999038983A1 Novel sphingosine-1 phosphate lyase
08/05/1999WO1999038982A1 Nucleic acid molecule encoding a cephalosporin acetylesterase
08/05/1999WO1999038981A2 Human protein kinase molecules
08/05/1999WO1999038980A2 Tyrosylprotein sulfotransferase polypeptides and polynucleotides
08/05/1999WO1999038979A1 Whisker-mediated transformation of plant cell aggregates and plant tissues and regeneration of plants thereof
08/05/1999WO1999038978A1 Methods and reagents for decreasing allergic reactions
08/05/1999WO1999038977A2 Plant having altered environmental stress tolerance
08/05/1999WO1999038975A2 Polynucleotide and polypeptide sequences associated with cns depressant sensitivity and methods of use thereof
08/05/1999WO1999038974A1 EQUINE Fc EPSILON RECEPTOR ALPHA CHAIN NUCLEIC ACID MOLECULES, CORRESPONDING PROTEINS AND USES THEREOF
08/05/1999WO1999038973A2 Compounds for therapy and diagnosis of lung cancer and methods for their use
08/05/1999WO1999038972A2 Human genes and gene expression products ii
08/05/1999WO1999038971A1 Protein binding to midkine
08/05/1999WO1999038970A1 Placental protein 13
08/05/1999WO1999038969A1 PROTEIN HUMAINE β-TrCP
08/05/1999WO1999038968A1 Recombinant proteins from hgf and msp
08/05/1999WO1999038967A2 Recombinant proteins derived from hgf and msp
08/05/1999WO1999038966A1 Wnt-10a
08/05/1999WO1999038964A2 Promoter regions of the mouse and human telomerase rna component genes
08/05/1999WO1999038963A1 Oligonucleotide sequences complementary to thioredoxin or thioredoxin reductase genes and methods of using same to modulate cell growth
08/05/1999WO1999038962A2 Compositions and methods for using a lysing matrix for isolating dna
08/05/1999WO1999038961A1 Gene regulator fusion proteins and methods of using the same for determining resistance of a protein to a drug targeted thereagainst
08/05/1999WO1999038959A1 Secreted proteins and polynucleotides encoding them
08/05/1999WO1999038957A1 GERMACRENE C SYNTHASE GENE OF $i(LYCOPERSICON ESCULENTUM)
08/05/1999WO1999038955A2 Mutant herpes simplex viruses and uses thereof
08/05/1999WO1999038954A1 A universal immunomodulatory cytokine-expressing bystander cell line and related compositions and methods of manufacture and use
08/05/1999WO1999038890A1 Erythropoietin with altered biological activity
08/05/1999WO1999038889A2 Modulation of sodium channels in dorsal root ganglia
08/05/1999WO1999038882A1 Human cystatin f
08/05/1999WO1999038881A1 67 human secreted proteins
08/05/1999WO1999038880A1 Genetic immunization with nonstructural proteins of hepatitis c virus
08/05/1999WO1999038874A2 Electrophoretic nucleic acid purification method
08/05/1999WO1999038821A2 Transfecting compositions sensitive to reducing conditions, pharmaceutical compositions containing them, and their applications
08/05/1999WO1999038612A1 Channel-less separation of bioparticles on a bioelectronic chip by dielectrophoresis
08/05/1999WO1999038531A1 TREATING ATOPIC DERMATITIS WITH IgE ANTAGONISTS
08/05/1999WO1999038523A1 CYTOKINE INDUCERS COMPRISING M161Ag
08/05/1999WO1999038377A1 Transgenic mouse model
08/05/1999WO1999029718A3 Bone morphogenetic protein (bmp)-17 and bmp-18 and compositions thereof
08/05/1999WO1999028474A3 Chemokine variants and methods of use
08/05/1999WO1999027096B1 A NOVEL EGF MOTIF PROTEIN OBTAINED FROM A cDNA LIBRARY OF FETAL LIVER-SPLEEN
08/05/1999WO1999025843A3 Human checkpoint kinase, hcds1, compositions and methods
08/05/1999WO1999025817A3 Tc1-based transposon vectors
08/05/1999WO1999024559A3 Nuclear targeting by means of streptococcal protein h
08/05/1999WO1999024472A3 Glycosylated antibodies and antibody fragments having reactive ketone groups
08/05/1999WO1999023216A3 Hyperthermic inducible expression vectors for gene therapy and methods of use thereof
08/05/1999WO1999023116B1 ASSAY EMPLOYING CadC FUSION PROTEINS
08/05/1999WO1999021999A3 Wnt-1 inducible genes
08/05/1999WO1999020799A3 Microorganism genomics, compositions and methods related thereto
08/05/1999WO1999020746A3 Plant phosphatases
08/05/1999WO1999020643A9 Using polyamide nucleic acid oligomers to engender a biological response
08/05/1999WO1999020121A9 Methods for obtaining protein mixtures and control factors from wound granulation, epithelialization or determined blastocyst tissue
08/05/1999WO1999019493A9 Cytochrome p-450 constructs and methods of producing herbicide-resistant transgenic plants
08/05/1999WO1999019359A8 Cellular receptor for hiv-1 vpr essential for g2/m phase transition of the cell cycle
08/05/1999WO1999019357A3 Cell regulatory genes, encoded products, and uses related thereto
08/05/1999WO1999018210A3 Compounds and methods for immunotherapy and immunodiagnosis of prostate cancer
08/05/1999WO1999018206A3 Human cancer antigen ny eso-1/cag-3 and gene encoding same
08/05/1999WO1999018202A3 HUMAN PROTEINS HAVING TRANSMEMBRANE DOMAINS AND cDNAs ENCODING THESE PROTEINS
08/05/1999WO1999018199A3 cDNAs CODING FOR HUMAN PROTEINS HAVING TRANSMEMBRANE DOMAINS
08/05/1999WO1999016780A3 Genetic sequences, diagnostic and/or quantification methods for the identification of staphylococci strains
08/05/1999WO1999014337A3 New plant genes
08/05/1999WO1999014322A3 Allelic variant of human stat3
08/05/1999WO1999014226A3 Bi- and tri-cyclic nucleoside, nucleotide and oligonucleotide analogues
08/05/1999WO1999013094A3 Fungal pathogenicity genes
08/05/1999WO1999013085A3 MICROBIAL GENES FOR SECRETED β-GLUCURONIDASES, GENE PRODUCTS AND USES THEREOF
08/05/1999WO1999011292A9 Compositions and methods for treating arthritis utilizing gene therapy
08/05/1999WO1999010358A3 Method for producing nucleic acid polymers
08/05/1999WO1999009216A9 Highly sensitive multimeric nucleic acid probes
08/05/1999WO1999009186A3 Polypeptide nucleic sequences exported from mycobacteria, vectors comprising same and uses for diagnosing and preventing tuberculosis
08/05/1999WO1999009151A3 Procedures and materials for conferring disease resistance in plants
08/05/1999WO1999006545A3 Composition and method for the detection of diseases associated with amyloid-like fibril or protein aggregate formation
08/05/1999WO1999005256A3 Method for cloning secreted proteins
08/05/1999WO1999000509A8 Nucleotide sequence coding for an enzyme having a acetolactate synthase activity, plant cell and plant containing it, and method for weeding plants
08/05/1999WO1998033901A9 Generation of diversity in combinatorial libraries
08/05/1999WO1997016206A8 Bladder nuclear matrix proteins and their use in detecting and treating cell proliferative disorders
08/05/1999WO1995031429A8 Photocleavable agents and conjugates for the detection and isolation of biomolecules
08/05/1999EP0920520A3 Nucleotide sequence coding for an enzyme having a acetolactate synthase activity, plant cell and plant containing it, and method for weeding plants
08/05/1999DE19849960A1 Reducing chlorophyll content in oilseeds
08/05/1999DE19804372A1 Verfahren zur quantitativen Bestimmung von Tumorzellen in einer Körperflüssigkeit und dazu geeignete Testkits A method for the quantitative determination of tumor cells in a body fluid and to test kits suitable
08/05/1999CA2746763A1 Whisker-mediated transformation of plant cell aggregates and plant tissues and regeneration of plants thereof
08/05/1999CA2319710A1 Oligonucleotide sequences complementary to thioredoxin or thioredoxin reductase genes and methods of using same to modulate cell growth
08/05/1999CA2319669A1 Mutant herpes simplex viruses and uses thereof
08/05/1999CA2319144A1 Recombinant proteins from hgf and msp
08/05/1999CA2319143A1 Modulation of sodium channels in dorsal root ganglia
08/05/1999CA2319129A1 67 human secreted proteins
08/05/1999CA2319117A1 Compounds for therapy and diagnosis of lung cancer and methods for their use
08/05/1999CA2319114A1 Gene regulator fusion proteins and methods of using the same for determining resistance of a protein to a drug targeted thereagainst
08/05/1999CA2319095A1 Pancreatic eukaryotic translation initiation factor-2.alpha. kinase
08/05/1999CA2319081A1 Human cystatin f
08/05/1999CA2318973A1 Electrophoretic nucleic acid purification method
08/05/1999CA2318911A1 Secreted proteins and polynucleotides encoding them
08/05/1999CA2318772A1 Methods to identify polynucleotide and polypeptide sequences which may be associated with physiological and medical conditions
08/05/1999CA2318744A1 Genetic immunization with nonstructural proteins of hepatitis c virus
08/05/1999CA2318522A1 Riboflavin biosynthesis genes from plants and uses thereof
08/05/1999CA2317814A1 Human protein kinase molecules
08/05/1999CA2317055A1 Improved method for the isolation of nucleic acid
08/05/1999CA2284847A1 Process for producing peptides using a helper peptide
08/04/1999EP0933429A1 Chimeric poxvirus comprising a retroviral vector genome
08/04/1999EP0933428A2 METHOD FOR INCREASING THE CONTENT OF TREHALOSE IN ORGANISMS THROUGH THE TRANSFORMATION THEREOF WITH THE cDNA OF THE TREHALOSE-6-PHOSPHATE SYNTHETASE/PHOSPHATASE OF SELAGINELLA LEPIDOPHYLLA
08/04/1999EP0933427A2 Beta-carotene hydroxylase gene
1 ... 3371 3372 3373 3374 3375 3376 3377 3378 3379 3380 3381 3382 3383 3384 3385 3386 3387 3388 3389 3390 3391 ... 4023